ORIGINAL PAPER
Prevalence of cardiovascular risk factors in adults registered in a primary health unit of Porto
1
Research Centre in Physical Activity, Health and Leisure, Faculty of Sport, University of Porto, Porto, Portugal
2
Primary Care Unit Espaço Saúde, Aldoar, Porto, Portugal
Submission date: 2020-07-14
Acceptance date: 2020-11-25
Publication date: 2021-10-26
Hum Mov. 2022;23(2):12-20
KEYWORDS
TOPICS
ABSTRACT
Purpose:
The study aims to describe the adult’s overall cardiovascular disease risk factors prevalence, including arterial stiffness and physical inactivity.
Methods:
The cross-sectional study involved 197 adults (males: 42%; mean age: 47 ± 13 years) from a Portuguese health centre. Traditional cardiovascular disease risk factors were measured during clinical assessment. Arterial stiffness was evaluated with carotid-femoral pulse wave velocity (≥ 10 m/s). Physical inactivity (< 30 min/day of moderate to vigorous physical activity) was objectively assessed with accelerometry. The statistical procedures included descriptive analysis (means, medians, and frequencies) and between-gender comparisons (chi-square test and t-test) for cardiovascular disease risk factors.
Results:
Cardiovascular disease risk factors prevalence was as follows: dyslipidaemia: 71%, physical inactivity: 51%, hypertension: 43%, metabolic syndrome: 36%, arterial stiffness: 31%, smoking: 29%, and obesity: 20%. The prevalence of cardiovascular disease risk factors increases with age and is higher in males than in females. The prevalence of hypertension and metabolic syndrome was higher in participants with a lower educational level. The majority of hypertensive patients were more physically inactive (56.5%) than active (43.5%; p = 0.044).
Conclusions:
The overall prevalence of cardiovascular disease risk factors was high, with 1/3 having augmented arterial stiffening and half being physically inactive.
The study aims to describe the adult’s overall cardiovascular disease risk factors prevalence, including arterial stiffness and physical inactivity.
Methods:
The cross-sectional study involved 197 adults (males: 42%; mean age: 47 ± 13 years) from a Portuguese health centre. Traditional cardiovascular disease risk factors were measured during clinical assessment. Arterial stiffness was evaluated with carotid-femoral pulse wave velocity (≥ 10 m/s). Physical inactivity (< 30 min/day of moderate to vigorous physical activity) was objectively assessed with accelerometry. The statistical procedures included descriptive analysis (means, medians, and frequencies) and between-gender comparisons (chi-square test and t-test) for cardiovascular disease risk factors.
Results:
Cardiovascular disease risk factors prevalence was as follows: dyslipidaemia: 71%, physical inactivity: 51%, hypertension: 43%, metabolic syndrome: 36%, arterial stiffness: 31%, smoking: 29%, and obesity: 20%. The prevalence of cardiovascular disease risk factors increases with age and is higher in males than in females. The prevalence of hypertension and metabolic syndrome was higher in participants with a lower educational level. The majority of hypertensive patients were more physically inactive (56.5%) than active (43.5%; p = 0.044).
Conclusions:
The overall prevalence of cardiovascular disease risk factors was high, with 1/3 having augmented arterial stiffening and half being physically inactive.
REFERENCES (30)
1.
Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007;14(Suppl. 2):1–40; doi: 10.1097/01.hjr.0000277984.31558.c4.
2.
Mendis S, Puska P, Norrving P (eds.). Global atlas on cardiovascular disease prevention and control. Geneva: World Health Organization; 2011.
3.
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10): 1953–2041; doi: 10.1097/HJH.0000000000001940.
4.
Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645; doi: 10.1161/CIRCULATIONAHA.109.192644.
5.
Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterials stiffness: a systematic review and metaanalysis. J Am Coll Cardiol. 2010;55(13):1318–1327; doi: 10.1016/j.jacc.2009.10.061.
6.
The Reference Values for Arterial Stiffness’ Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’. Eur Heart J. 2010;31(19):2338–2350; doi: 10.1093/eurheartj/ehq165.
7.
Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27(21):2588–2605; doi: 10.1093/eurheartj/ehl254.
8.
Bohn L, Ramoa A, Silva G, Silva N, Abreu SM, Ribeiro F, et al. Sedentary behavior and arterial stiffness in adults with and without metabolic syndrome. Int J Sports Med. 2017;38(5):396–401; doi: 10.1055/s-0043-101676.
9.
Bays HE, Jones PH, Orringer CE, Brown WV, Jacobson TA. National Lipid Association Annual Summary of Clinical Lipidology 2016. J Clin Lipidol. 2016;10(1 Suppl.):S1–S43; doi: 10.1016/j.jacl.2015.08.002.
10.
Troiano RP, Berrigan D, Dodd KW, Mâsse LC, Tilert T, McDowell M. Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc. 2008;40(1):181–188; doi: 10.1249/mss.0b013e31815a51b3.
11.
Haskell WL, Lee I-M, Pate RR, Powell KE, Blair SN, Franklin BA, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation. 2007;116(9):1081–1093; doi: 10.1161/CIRCULATIO NAHA.107.185649.
12.
Friões F, Azevedo A, Castro A, Alvelos M, Pimenta J, Vazquez B, et al. Impact of cardiovascular risk factors in an urban sample of Portuguese adults according to the Framingham risk prediction models. Rev Port Cardiol. 2003;22(4):511–520.
13.
Alves L, Azevedo A, Silva S, Barros H. Socioeconomic inequalities in the prevalence of nine established cardiovascular risk factors in a southern European population. PLoS One. 2012;7(5):e37158; doi: 10.1371/journal.pone.0037158.
15.
Guthold R, Stevens GA, Riley LM, Bull FC. Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1.9 million participants. Lancet Glob Health. 2018;6(10):e1077–e1086; doi: 10.1016/S2214-109X(18)30357-7.
16.
Fiuza-Luces C, Garatachea N, Berger NA, Lucia A. Exercise is the real polypill. Physiology. 2013;28(5):330–358; doi: 10.1152/physiol.00019.2013.
17.
Kelley GA, Kelley KS, Roberts S, Haskell W. Comparison of aerobic exercise, diet or both on lipids and lipoproteins in adults: a meta-analysis of randomized controlled trials. Clin Nutr. 2012;31(2):156–167; doi: 10.1016/j.clnu.2011.11.011.
18.
Umpierre D, Ribeiro PAB, Kramer CK, Leitão CB, Zucatti ATN, Azevedo MJ, et al. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA. 2011;305(17):1790–1799; doi: 10.1001/jama.2011.576.
19.
Cornelissen VA, Smart NA. Exercise training for blood pressure: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2(1):e004473; doi: 10.1161/JAHA.112.004473.
20.
Ozemek C, Laddu DR, Lavie CJ, Claeys H, Kaminsky LA, Ross R, et al. An update on the role of cardiorespiratory fitness, structured exercise and lifestyle physical activity in preventing cardiovascular disease and health risk. Prog Cardiovasc Dis. 2018;61(5–6):484–490; doi: 10.1016/j.pcad.2018.11.005.
21.
Polonia J, Martins L, Pinto F, Nazare J. Prevalence, awareness, treatment and control of hypertension and salt intake in Portugal: changes over a decade. The PHYSA study. J Hypertens. 2014;32(6):1211–1221; doi: 10.1097/HJH.0000000000000162.
22.
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC practice guidelines for the management of arterial hypertension. Blood Press. 2014;23(1):3–76; doi: 10.3109/08037051.2014.868629.
23.
International Diabetes Federation. ID F consensus worldwide definition of the metabolic syndrome. Available from: http://www.idf.org/metabolic-s....
24.
Santos A-C, Barros H. Impact of metabolic syndrome definitions on prevalence estimates: a study in a Portuguese community. Diab Vasc Dis Res. 2007;4(4):320–327; doi: 10.3132/dvdr.2007.059.
25.
Cunha PG, Cotter J, Oliveira P, Vila I, Boutouyrie P, Laurent S, et al. Pulse wave velocity distribution in a cohort study: from arterial stiffness to early vascular aging. J Hypertens. 2015;33(7):1438–1445; doi: 10.1097/HJH.0000000000000565.
26.
1st national health survey with physical examination: health determinants [in Portuguese]. Lisboa: INSA; 2017.
27.
De Oliveira-Martins S, Oliveira T, Gomes JJF, Caramona M, Cabrita J. Factors associated with arterial hypertension in pharmacy users in Portugal. Rev Saude Publica. 2011;45(1):136–144; doi: 10.1590/s0034-89102010005000056.
28.
National health survey 2014 [in Portuguese]. Lisboa: Instituto Nacional de Estatística; 2016.
29.
Lavie CJ, McAuley PA, Church TS, Milani RV, Blair SN. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol. 2014;63(14):1345–1354; doi: 10.1016/j.jacc.2014.01.022.
30.
Kaplan GA, Keil JE. Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation. 1993;88(4 Pt 1):1973–1998; doi: 10.1161/01.cir.88.4.1973.
Share
RELATED ARTICLE
| eISSN: | 1899-1955 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
